As a clinically researched immune activator* supported by 30 published studies, including 15 human trials, IMMUSE is a postbiotic that delivers a new, breakthrough approach to broad-range immune support*
Very real
To maximize the healing benefits of BPC-157 for an injury, consider timing your dosage around moments when you experience elevated physical activity or exertion in that area
Tumour tissue immunohistochemistry (IHC) staining was performed using standard techniques as described previously (Ma et al, 2005) with antibodies against the following proteins: HGF (Zymed-Invitrogen, Carlsbad, CA, USA), c-MET (3D4 monoclonal
Reducing the risk of worsening kidney disease, kidney failure, and cardiovascular death in patients with chronic kidney disease and type 2 diabetes